Form 4: Biodesix Executive Kieran O'Kane Reports Stock Transactions
SEC Form 4
Kieran O'Kane, Chief Commercial Officer of Biodesix Inc., reports the vesting and sale of restricted stock units to cover taxes, along with adjustments to his direct ownership of common stock.
Summary
- Kieran O'Kane, the Chief Commercial Officer of Biodesix Inc., filed a Form 4 detailing changes in beneficial ownership.
- On February 10, 2025, O'Kane acquired 48,118 shares of common stock through the vesting of restricted stock units (RSUs).
- On February 11, 2025, O'Kane sold 17,527 shares of common stock at a weighted average price of $0.9242 per share to cover taxes associated with the vesting of the RSUs.
- Following these transactions, O'Kane directly owns 128,039 shares of Biodesix common stock.
- The RSUs vest in installments over several years, contingent upon O'Kane's continued service with Biodesix.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock transactions for tax purposes, so the sentiment is neutral.
Industry Context
Executive stock transactions are a normal part of corporate governance and compensation practices. Monitoring these transactions can provide insights into management's perspective on the company's performance and future prospects.
Stakeholder Impact
- Shareholders may be interested in executive stock transactions as an indicator of management's confidence in the company.
- Employees who also hold RSUs may be interested in the vesting schedules and tax implications.
Key Dates
| Date | Description |
|---|---|
| 02/08/2022 | Start date for vesting of some RSUs in sixteen successive quarterly installments. |
| 02/08/2023 | Start date for vesting of some RSUs in four successive equal annual installments. |
| 01/15/2024 | Start date for vesting of some RSUs in four successive equal annual installments. |
| 02/10/2025 | Date of RSU vesting and acquisition of 48,118 shares. |
| 02/11/2025 | Date of sale of 17,527 shares at an average price of $0.9242. |
| 02/12/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.